CNS Pharmaceuticals
Stock Forecast, Prediction & Price Target

CNS Pharmaceuticals Financial Estimates

CNS Pharmaceuticals Revenue Estimates

CNS Pharmaceuticals EBITDA Estimates

CNS Pharmaceuticals Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $23.19M
Low: $23.19M
High: $23.19M
avg. 0%
Avg: $40.75M
Low: $40.75M
High: $40.75M
avg. 75.69%
Avg: $83.98M
Low: $83.98M
High: $83.98M
avg. 106.04%
Net Income
 
% change YoY
$-14.04M
 
N/A
$-15.28M
 
-8.79%
$-18.85M
 
-23.36%
Avg: $-41.90M
Low: $-919.24K
High: $-919.24K
avg. -122.27%
Avg: $-19.17M
Low: $-19.17M
High: $-19.17M
avg. 54.23%
Avg: $11.30M
Low: $11.30M
High: $11.30M
avg. 158.93%
EBITDA
 
% change YoY
$-14.01M
 
N/A
$-15.25M
 
-8.85%
$-18.86M
 
-23.63%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$15.99
 
N/A
-$11.22
 
29.83%
-$251.35
 
-2140.19%
Avg: -$12.2
Low: -$12.2
High: -$12.2
avg. 95.14%
Avg: -$254.5
Low: -$254.5
High: -$254.5
avg. -1986.06%
Avg: $150
Low: $150
High: $150
avg. 158.93%
Operating Expenses
 
% change YoY
$14.02M
 
N/A
$15.26M
 
8.83%
$18.86M
 
23.56%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is CNS Pharmaceuticals stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 30.29% in 2025-2027.

We have gathered data from 1 analysts. Their low estimate is -919.24K, average is -41.90M and high is -919.24K.

What is CNS Pharmaceuticals stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 60.57% in 2025-2027.

We have gathered data from N/A analysts. Their low revenue estimate is $23.19M, average is $23.19M and high is $23.19M.

What is CNS Pharmaceuticals stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of -577.32% in 2025-2027.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$12.2, average is -$12.2 and high is $-12.2.